Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly

Schizophr Res. 2023 Oct:260:183-190. doi: 10.1016/j.schres.2023.08.026. Epub 2023 Sep 6.
No abstract available

Keywords: Aripiprazole; Biostatistics; Constrained confidence partitioning; Long-acting injectable; Prediction; Response; Schizophrenia; Structure detection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Aripiprazole / adverse effects
  • Delayed-Action Preparations / therapeutic use
  • Humans
  • Piperazines / therapeutic use
  • Schizophrenia* / chemically induced
  • Schizophrenia* / drug therapy

Substances

  • Aripiprazole
  • Antipsychotic Agents
  • Piperazines
  • Delayed-Action Preparations